Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gastrointestinal Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Cancer Treatmentmarket, defines the market attractiveness level of Gastrointestinal Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gastrointestinal Cancer Treatment industry, describes the types of Gastrointestinal Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Cancer Treatment market and the development prospects and opportunities of Gastrointestinal Cancer Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Cancer Treatment market in Chapter 13.
By Player:
GlaxoSmithKline
Eli Lilly
Boston Scientific Corporation
CONMED Corporation
Novartis AG
Otsuka Holdings
F Hoffmann
Stryker Corporation
Merck
Johnson and Johnson
By Type:
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
By End-User:
Hospitals
Clinics
Research Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gastrointestinal Cancer Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gastrointestinal Cancer Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gastrointestinal Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gastrointestinal Cancer Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gastrointestinal Cancer Treatment Market Analysis and Outlook to 2022
-
7.1 Global Gastrointestinal Cancer Treatment Consumption (2017-2022)
-
7.2 United States Gastrointestinal Cancer Treatment Consumption (2017-2022)
-
7.3 Europe Gastrointestinal Cancer Treatment Consumption (2017-2022)
-
7.4 China Gastrointestinal Cancer Treatment Consumption (2017-2022)
-
7.5 Japan Gastrointestinal Cancer Treatment Consumption (2017-2022)
-
7.6 India Gastrointestinal Cancer Treatment Consumption (2017-2022)
-
7.7 South Korea Gastrointestinal Cancer Treatment Consumption (2017-2022)
8 Region and Country-wise Gastrointestinal Cancer Treatment Market Analysis and Outlook to 2028
-
8.1 Global Gastrointestinal Cancer Treatment Consumption Forecast (2022-2028)
-
8.2 United States Gastrointestinal Cancer Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Gastrointestinal Cancer Treatment Consumption Forecast (2022-2028)
-
8.4 China Gastrointestinal Cancer Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Gastrointestinal Cancer Treatment Consumption Forecast (2022-2028)
-
8.6 India Gastrointestinal Cancer Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Gastrointestinal Cancer Treatment Consumption Forecast (2022-2028)
9 Global Gastrointestinal Cancer Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal Cancer Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Targeted Drugs Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Chemo Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Adjuvant Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal Cancer Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Gastrointestinal Cancer Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Targeted Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Chemo Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Adjuvant Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Gastrointestinal Cancer Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gastrointestinal Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gastrointestinal Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gastrointestinal Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gastrointestinal Cancer Treatment Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Service
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Details
-
14.2.2 Eli Lilly Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly Gastrointestinal Cancer Treatment Product and Service
-
14.3 Boston Scientific Corporation
-
14.3.1 Boston Scientific Corporation Company Details
-
14.3.2 Boston Scientific Corporation Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Service
-
14.4 CONMED Corporation
-
14.4.1 CONMED Corporation Company Details
-
14.4.2 CONMED Corporation Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CONMED Corporation Gastrointestinal Cancer Treatment Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Gastrointestinal Cancer Treatment Product and Service
-
14.6 Otsuka Holdings
-
14.6.1 Otsuka Holdings Company Details
-
14.6.2 Otsuka Holdings Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Product and Service
-
14.7 F Hoffmann
-
14.7.1 F Hoffmann Company Details
-
14.7.2 F Hoffmann Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 F Hoffmann Gastrointestinal Cancer Treatment Product and Service
-
14.8 Stryker Corporation
-
14.8.1 Stryker Corporation Company Details
-
14.8.2 Stryker Corporation Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Stryker Corporation Gastrointestinal Cancer Treatment Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Gastrointestinal Cancer Treatment Product and Service
-
14.10 Johnson and Johnson
-
14.10.1 Johnson and Johnson Company Details
-
14.10.2 Johnson and Johnson Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Johnson and Johnson Gastrointestinal Cancer Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gastrointestinal Cancer Treatment
-
Figure Gastrointestinal Cancer Treatment Picture
-
Table Global Gastrointestinal Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gastrointestinal Cancer Treatment Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Gastrointestinal Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Cancer Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Drugs Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemo Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Adjuvant Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemo Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adjuvant Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gastrointestinal Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gastrointestinal Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Gastrointestinal Cancer Treatment Product and Service
-
Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)
-
Table Boston Scientific Corporation Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Service
-
Table CONMED Corporation (Foundation Year, Company Profile and etc.)
-
Table CONMED Corporation Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CONMED Corporation Gastrointestinal Cancer Treatment Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Gastrointestinal Cancer Treatment Product and Service
-
Table Otsuka Holdings (Foundation Year, Company Profile and etc.)
-
Table Otsuka Holdings Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Holdings Gastrointestinal Cancer Treatment Product and Service
-
Table F Hoffmann (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann Gastrointestinal Cancer Treatment Product and Service
-
Table Stryker Corporation (Foundation Year, Company Profile and etc.)
-
Table Stryker Corporation Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stryker Corporation Gastrointestinal Cancer Treatment Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Gastrointestinal Cancer Treatment Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Gastrointestinal Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Gastrointestinal Cancer Treatment Product and Service
-
